Insider · CIK 0002123975
Ugur Sahin
Files at BNTX (BioNTech SE). First filing Sep 8, 2026, latest Oct 9, 2026.
In brief
Ugur Sahin files SEC Form 4 as CEO and 10% owner at BNTX (BioNTech SE). Since Sep 8, 2026, Ugur Sahin has reported 0 open-market buys worth $0 and 14 open-market sells worth $84M, the latest filed on Oct 9, 2026.
A track record needs three past buys with six months of prices behind them; Ugur Sahin has 0, so none is measured yet.
The newest scored trade: sold $5.9M of BNTX on Oct 8, 2026, filed Oct 9, 2026, scored 50 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 14 sells worth $84M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BNTX: BioNTech SE
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | BioNTech SE | $5.9M 63,209 shares | -100% | +10% from low-23% from high | |
| 40Moderate | BioNTech SE | $2.3M 24,000 shares | -28% | +14% from low-20% from high | |
| 50Moderate | BioNTech SE | $9.0M 93,000 shares | -52% | +16% from low-18% from high | |
| 35Weak | BioNTech SE | $3.3M 34,000 shares | -16% | +15% from low-19% from high | |
| 35Weak | BioNTech SE | $6.5M 66,000 shares | -24% | +18% from low-17% from high | |
| 35Weak | BioNTech SE | $6.0M 61,000 shares | -18% | +17% from low-17% from high | |
| 35Weak | BioNTech SE | $6.8M 69,000 shares | -17% | +17% from low-18% from high | |
| 35Weak | BioNTech SE | $7.9M 79,000 shares | -16% | +17% from low-18% from high | |
| 35Weak | BioNTech SE | $6.2M 64,000 shares | -12% | +18% from low-17% from high | |
| 30Weak | BioNTech SE | $4.7M 49,000 shares | -8% | - | |
| 35Weak | BioNTech SE | $8.4M 86,000 shares | -12% | - | |
| 30Weak | BioNTech SE | $2.0M 20,500 shares | -3% | - | |
| 30Weak | BioNTech SE | $7.2M 73,000 shares | -9% | - | |
| 30Weak | BioNTech SE | $7.9M 76,500 shares | -9% | - |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -27,000 | $92.31 | $2.5M | 36,209 | 4 d ago |
| Oct 9, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -36,209 | $95.37 | $3.5M | 0 | 4 d ago |
| Oct 7, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -24,000 | $95.86 | $2.3M | 63,209 | 6 d ago |
| Oct 5, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -72,000 | $97.23 | $7.0M | 108,209 | 7 d ago |
| Oct 6, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -21,000 | $96.81 | $2.0M | 87,209 | 7 d ago |
| Oct 1, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -17,000 | $97.46 | $1.7M | 197,209 | 11 d ago |
| Oct 2, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -17,000 | $96.72 | $1.6M | 180,209 | 11 d ago |
| Sep 29, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -34,000 | $98.26 | $3.3M | 246,209 | 13 d ago |
| Sep 30, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -32,000 | $98.12 | $3.1M | 214,209 | 13 d ago |
| Sep 25, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -27,000 | $98.69 | $2.7M | 314,209 | 15 d ago |
| Sep 28, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -34,000 | $98.47 | $3.3M | 280,209 | 15 d ago |
| Sep 23, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -30,000 | $99.40 | $3.0M | 380,209 | 19 d ago |
| Sep 24, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -39,000 | $98.99 | $3.9M | 341,209 | 19 d ago |
| Sep 21, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -33,000 | $97.81 | $3.2M | 456,209 | 21 d ago |
| Sep 22, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -46,000 | $100.72 | $4.6M | 410,209 | 21 d ago |
| Sep 17, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -34,000 | $98.60 | $3.4M | 519,209 | 25 d ago |
| Sep 18, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -30,000 | $96.22 | $2.9M | 489,209 | 25 d ago |
| Sep 15, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -34,000 | $96.49 | $3.3M | 568,209 | 27 d ago |
| Sep 16, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -15,000 | $96.09 | $1.4M | 553,209 | 27 d ago |
| Sep 11, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -45,000 | $96.93 | $4.4M | 643,209 | 29 d ago |
| Sep 14, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -41,000 | $99.45 | $4.1M | 602,209 | 29 d ago |
| Sep 10, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -20,500 | $96.31 | $2.0M | 688,209 | 32 d ago |
| Sep 8, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -37,000 | $99.20 | $3.7M | 744,709 | 34 d ago |
| Sep 9, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -36,000 | $97.78 | $3.5M | 708,709 | 34 d ago |
| Sep 3, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -45,000 | $102.85 | $4.6M | 813,209 | 35 d ago |
| Sep 4, 2026 | BNTX BioNTech SE | SOpen-market sale Ordinary Shares10b5-1 | -31,500 | $103.52 | $3.3M | 781,709 | 35 d ago |
Questions about Ugur Sahin
Answered from the filings on this page, as of the latest one.
Is Ugur Sahin buying or selling?
In the last 12 months Ugur Sahin reported 0 open-market buys worth $0 and 14 open-market sells worth $84M on SEC Form 4; the latest was sold $5.9M of BNTX on Oct 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Ugur Sahin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ugur Sahin has 0.
Where does Ugur Sahin file Form 4?
Ugur Sahin has filed Form 4 at BNTX (BioNTech SE) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.